ライフサイエンスコーパス: pancreatic resection

1 andidates to IAT (accounting for 7.5% of all pancreatic resections).

2 Hepatic or pancreatic resection.

3 ot be considered mandatory or standard after pancreatic resection.

4 inage placed in a standardized fashion after pancreatic resection.

5 native somatostatin) in patients undergoing pancreatic resection.

6 associated with successful pain relief after pancreatic resection.

7 Center identified 332 patients who underwent pancreatic resection.

8 ent of POPF nearly doubled the total cost of pancreatic resection.

9 ity of widespread pasireotide application in pancreatic resection.

10 r to complications and death associated with pancreatic resection.

11 nd risk factors for 30-day readmission after pancreatic resection.

12 substantial saving in operative time during pancreatic resection.

13 I and total costs and charges for hepatic or pancreatic resection.

14 stoperative morbidity in patients undergoing pancreatic resection.

15 independent risk factor for mortality after pancreatic resection.

16 en hundred and thirty-six patients underwent pancreatic resection.

17 h modern imaging to avoid unsuccessful blind pancreatic resection.

18 re--from 1.24 for lung resection to 3.61 for pancreatic resection.

19 rgical procedures included esophagectomy and pancreatic resection.

20 eal drains has been considered routine after pancreatic resection.

21 ntraperitoneal closed suction drainage after pancreatic resection.

22 tologous substitute during complex liver and pancreatic resections.

23 our knowledge the largest series of robotic pancreatic resections.

24 niotomy, 77 for esophageal resection, 86 for pancreatic resection, 138 for pediatric heart surgery, 1

25 e hospitals ranged from over 12 percent (for pancreatic resection, 16.3 percent vs. 3.8 percent) to o

26 ), repair of abdominal aortic aneurysm (8%), pancreatic resection (2%), esophageal resection (1%), an

27 d at 2 hospitals with HV for either liver or pancreatic resection (2009-2012).

28 trectomy 23.4%; antireflux procedures 23.4%; pancreatic resection 37.4%; liver resection 29.3%; endoc

29 ansfusion (of 13657 patients who underwent a pancreatic resection, 4074 required transfusion [29.8%];

30 an abdominal aortic aneurysm, 55 percent for pancreatic resection, 49 percent for coronary-artery byp

31 nal volume was associated with lower cost of pancreatic resection (-5.4%; 95% CI, -10.0% to -0.5%; P

32 Weighted totals of 38711 patients undergoing pancreatic resection (50.8% men and 49.2% women; median

33 Colon resection (37.7% of hospitals), pancreatic resection (7.1% of hospitals), and laparoscop

34 e surgical and clinicopathologic outcomes of pancreatic resections after neoadjuvant FOLFIRINOX thera

35 tomatic, it becomes important in cases where pancreatic resection/anastomosis is planned, because of

36 The history of prior pancreatic resection and drainage procedures may be used

37 as predictors of subsequent performance for pancreatic resection and elective abdominal aortic aneur

38 reduction in the morbidity and mortality of pancreatic resection and improvement in the actuarial 5-

39 f pancreatic carcinoma with a combination of pancreatic resection and intraoperative radiation therap

40 carotid endarterectomy, radical cystectomy, pancreatic resection, and esophagectomy.

41 denectomy, 11 patients underwent non-Whipple pancreatic resections, and 5 underwent simple enucleatio

42 nderwent colorectal resection; 1660 (40.4%), pancreatic resection; and 694 (16.9%), hepatic resection

43 actors determining short-term survival after pancreatic resection are well studied, but prognostic fa

44 An increasing number of pancreatic resections are being performed using minimall

45 s with non-neoplastic diseases who underwent pancreatic resection at Johns Hopkins Hospital between 2

46 eased mortality in older patients undergoing pancreatic resection at specialized centers.

47 review of a prospective database of robotic pancreatic resections at a single institution between Au

48 IPMNs represent an increasing indication for pancreatic resection, but little is known about the actu

49 olling for patient demographics and factors, pancreatic resection by a HV surgeon in this case-contro

50 ients with abdominal aortic aneurysm repair, pancreatic resection, colectomy, and appendectomy.

51 For pancreatic resections, costs were 5.5% higher (95% CI, 0

52 Routine prophylactic drainage after pancreatic resection could be safely abandoned.

53 A single institution's prospective pancreatic resection database was retrospectively review

54 The pancreatic resection databases of 3 institutions (design

55 In addition to the traditional methods of pancreatic resection (eg, standard Whipple and pylorus-p

56 r in high-volume hospitals for 3 procedures (pancreatic resection, esophagectomy, cystectomy), but lo

57 All patients undergoing pancreatic resection for an IPMN at the Johns Hopkins Ho

58 All patients who underwent pancreatic resection for an IPMN at the Johns Hopkins Ho

59 the National Cancer Data Base who underwent pancreatic resection for cancer were linked (2006-2009).

60 e 13-year time period, 60 patients underwent pancreatic resection for IPMNs, with 40 patients undergo

61 for 21 consecutive MEN 1 patients undergoing pancreatic resection for NETs between 1993 and 1999 at o

62 om 89 consecutive patients who had undergone pancreatic resection for pancreatic adenocarcinoma with

63 The survival benefit of extended pancreatic resection for pancreatic cancer remains dubio

64 sed on prospectively collected data from 555 pancreatic resections for adenocarcinoma at a single ins

65 Improved management of pancreatic resections for cancer with more extensive and

66 was performed using all patients undergoing pancreatic resections for neoplastic disease identified

67 Extensive pancreatic resections for SAP became the vogue in contin

68 We identified 2694 patients who underwent pancreatic resection from the American College of Surgeo

69 Three of 5 HRIs who underwent pancreatic resection had high-grade dysplasia in less th

70 ents who receive octreotide during and after pancreatic resection have a reduction in the total numbe

71 ive bypass, relieve pain, and perform distal pancreatic resections have been described.

72 %, distal pancreatectomy in 12%, and central pancreatic resection in 2%.

73 lvement should not be a contraindication for pancreatic resection in patients with adenocarcinoma.

74 included all patients undergoing hepatic or pancreatic resection in the Nationwide Inpatient Sample

75 We identified all pancreatic resections in Texas from 1999 to 2005.

76 Pancreatic resections, including pancreaticoduodenectomy

77 Readmission after pancreatic resection is common and can largely be attrib

78 Hospital readmission after pancreatic resection is common and costly.

79 Pancreatic resection is the standard treatment option fo

80 ng all patients and subsets of patients with pancreatic resection, laparoscopic cholecystectomy, cole

81 (N = 55,466) who underwent colon resection, pancreatic resection, laparoscopic gastric bypass, ventr

82 More extensive pancreatic resections lead to higher morbidity.

83 Venous resection during liver or pancreatic resection may require a rapidly available sub

84 Patients who underwent pancreatic resection of MCNs at the 8 academic centers o

85 tcomes than their counterparts who underwent pancreatic resection only.

86 ncreatic gastrinomas underwent either distal pancreatic resections or gastrinoma enucleation with lym

87 tions in nonneoplastic ducts supports formal pancreatic resection over enucleation for treatment.

88 ients with pancreatic cancer who underwent a pancreatic resection, palliative bypass, or stent proced

89 s with LAPC underwent IRE alone (n = 150) or pancreatic resection plus IRE for margin enhancement (n

90 Improved outcomes after pancreatic resection (PR) by high volume (HV) surgeons h

91 al procedure volume as a quality measure for pancreatic resection (PR), abdominal aortic aneurysm (AA

92 PURPOSE OF REVIEW: Pancreatic resection remains among the most formidable a

93 asectomy is most often done through a formal pancreatic resection such as pancreaticoduodenectomy or

94 The use of the robotic platform for complex pancreatic resections, such as the pancreaticoduodenecto

95 g the 42 480 patients who underwent liver or pancreatic resection, the median age was 62 years, 52.4%

96 tive tool that reduces the number of aborted pancreatic resections; there is no evidence from this re

97 recently shown to decrease leak rates after pancreatic resection, though the significant cost of the

98 icoduodenectomy is not improved by extending pancreatic resections to achieve negative margins after

99 We applied this technology to a variety of pancreatic resections to assess the safety, feasibility,

100 to compare pasireotide administration after pancreatic resection versus usual care, populated by pro

101 elative risk (RR) of in-hospital death after pancreatic resection was 19.3 and 8 at the low- and medi

102 patients who underwent potentially curative pancreatic resection was analyzed.

103 he use of intraperitoneal drainage following pancreatic resection was published from our institution

104 Patients scheduled to undergo pancreatic resection were consented for randomization to

105 tion, major perioperative complications from pancreatic resection were not significantly influenced b

106 A total of 250 consecutive robotic pancreatic resections were analyzed; pancreaticoduodenec

107 Major pancreatic resections were associated with mortality ran

108 January 1987 and March 2003, inclusive, 136 pancreatic resections were performed for patients with I

109 tervention before malignant spread and major pancreatic resection where indicated, appears justified.

110 Pancreatic resection with autologous islet transplantati

111 need for routine prophylactic drainage after pancreatic resection with pancreaticojejunal anastomosis

112 involvement of the portal vein and underwent pancreatic resection with PVR.

113 Patients who underwent pancreatic resection with VR were at a higher risk for i

114 Extended pancreatic resections with vascular resection appear saf

115 lly different from those patients undergoing pancreatic resection without PVR (17 months (range, < 1-

116 Patients undergoing curative pancreatic resection without PVR over this same time per

117 Whereas low-volume (L-V) hospitals (< or =10 pancreatic resections/y) had higher mortality rates (3.2

118 resected at high-volume (H-V) hospitals (>10 pancreatic resections/y).